CARA SCHIESSLER: Open Payments
NPI 1184959520 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 48 payments from 16 companies in 2025. Trend: 2023 $6,730 · 2024 $4,003 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 5 | $238 |
| Sumitomo Pharma America, Inc. | 21 | $169 |
| Boston Scientific Corporation | 2 | $163 |
| Galvanize Therapeutics, Inc | 1 | $122 |
| Janssen Biotech, Inc. | 3 | $55 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| Antares Pharma, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| ABBVIE INC. | 2 | $31 |
| ACCORD HEALTHCARE, INC. | 1 | $27 |
Products named: JELMYTO, ORGOVYX, AMS 700, ALIYA SYSTEM, ZUSDURI, ERLEADA, KEYTRUDA, XYOSTED.
Industry payments across NE — which companies pay providers there.
